GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mizuho Medy Co Ltd (TSE:4595) » Definitions » EV-to-FCF

Mizuho Medy Co (TSE:4595) EV-to-FCF : (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mizuho Medy Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Mizuho Medy Co's Enterprise Value is 円22,355 Mil. Mizuho Medy Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil. Therefore, Mizuho Medy Co's EV-to-FCF for today is .

The historical rank and industry rank for Mizuho Medy Co's EV-to-FCF or its related term are showing as below:

TSE:4595' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 148.97
Current: 6.1

During the past 10 years, the highest EV-to-FCF of Mizuho Medy Co was 148.97. The lowest was 0.00. And the median was 0.00.

TSE:4595's EV-to-FCF is ranked better than
88.83% of 537 companies
in the Drug Manufacturers industry
Industry Median: 22.8 vs TSE:4595: 6.10

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Mizuho Medy Co's stock price is 円3375.00. Mizuho Medy Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was 円419.828. Therefore, Mizuho Medy Co's PE Ratio for today is 8.04.


Mizuho Medy Co EV-to-FCF Historical Data

The historical data trend for Mizuho Medy Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mizuho Medy Co EV-to-FCF Chart

Mizuho Medy Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,607.53 64.47 3.33 4.51 5.31

Mizuho Medy Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 5.31 -

Competitive Comparison of Mizuho Medy Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Mizuho Medy Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mizuho Medy Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mizuho Medy Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Mizuho Medy Co's EV-to-FCF falls into.



Mizuho Medy Co EV-to-FCF Calculation

Mizuho Medy Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=22354.745/0
=

Mizuho Medy Co's current Enterprise Value is 円22,355 Mil.
Mizuho Medy Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mizuho Medy Co  (TSE:4595) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Mizuho Medy Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3375.00/419.828
=8.04

Mizuho Medy Co's share price for today is 円3375.00.
Mizuho Medy Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円419.828.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Mizuho Medy Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Mizuho Medy Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Mizuho Medy Co (TSE:4595) Business Description

Traded in Other Exchanges
N/A
Address
4 Fujinoki-Machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.

Mizuho Medy Co (TSE:4595) Headlines

No Headlines